Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared a post 0n X by Cancer Therapy Advisor, adding:
“One of my favorite abstracts from Tandem25.
Median patient-reported hair loss with a scalp cooling device during ASCT for myeloma only 2.5%!! Led by Bobvescio of Cedars-Sinai.
We have to get this to more patients for sure!”
Quoting Cancer Therapy Advisor’s post:
“A scalp cooling device appeared to minimize hair loss in a study of patients undergoing high-dose chemo and ASCT. Written by Rahul Banerjee of Fred Hutchinson Cancer Center.”
More posts featuring Rahul Banerjee and Cancer Therapy Advisor.